000 02466 a2200709 4500
005 20250517002905.0
264 0 _c20160224
008 201602s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdu539
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHebbar, M
245 0 0 _aFOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cFeb 2015
300 _a340-7 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOrganoplatinum Compounds
_xadministration & dosage
650 0 4 _aProportional Hazards Models
700 1 _aChibaudel, B
700 1 _aAndré, T
700 1 _aMineur, L
700 1 _aSmith, D
700 1 _aLouvet, C
700 1 _aDutel, J L
700 1 _aYchou, M
700 1 _aLegoux, J L
700 1 _aMabro, M
700 1 _aFaroux, R
700 1 _aAuby, D
700 1 _aBrusquant, D
700 1 _aKhalil, A
700 1 _aTruant, S
700 1 _aHadengue, A
700 1 _aDalban, C
700 1 _aGayet, B
700 1 _aPaye, F
700 1 _aPruvot, F R
700 1 _aBonnetain, F
700 1 _aTaieb, J
700 1 _aBrucker, P
700 1 _aLandi, B
700 1 _aFlesch, M
700 1 _aCarola, E
700 1 _aMartin, P
700 1 _aVaillant, E
700 1 _ade Gramont, A
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 26
_gno. 2
_gp. 340-7
856 4 0 _uhttps://doi.org/10.1093/annonc/mdu539
_zAvailable from publisher's website
999 _c24360110
_d24360110